Pseudoacondroplasia: diagnostic analysis and multidisciplinary approach to a patient with congenital and tall basal escoliosis
PDF (Español (España))
html (Español (España))

Keywords

Pseudoachondroplasia
bone dysplasia
case report
disproportionate short stature
congenital scoliosis
osteopenia
genetic mutation
multidisciplinary management
early diagnosis
extracellular matrix proteins

How to Cite

Calvopiña Rea , J. A., Reyes, C. A., & Baquero , S. (2025). Pseudoacondroplasia: diagnostic analysis and multidisciplinary approach to a patient with congenital and tall basal escoliosis. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 12(4). https://doi.org/10.53853/encr.12.4.960

Abstract

Background: Pseudoachondroplasia (PSACH) is a rare skeletal dysplasia with autosomal dominant inheritance, caused by mutations in the COMP gene. It is characterized by disproportionate short stature, progressive skeletal deformities, and joint laxity, without cognitive impairment or growth hormone axis involvement. Early diagnosis is essential to avoid unnecessary endocrine evaluations and treatments.

Purpose: To describe the clinical case of a patient with PSACH associated with congenital scoliosis and short stature, emphasizing the importance of differential diagnosis from the endocrinology perspective and the need for timely multidisciplinary management.

Case presentation: We present a 20-year-old female with congenital scoliosis and severe short stature (111.5 cm; -8.89 SD), with progressive limb deformities. Physical examination revealed rhizomelic shortening, relative macrocephaly, and distinctive facial features. Whole-exome sequencing confirmed a heterozygous pathogenic variant c.1159T>G (p.Cys387Gly) in the COMP gene. Bone densitometry showed severe osteopenia in the spine and femur, with normal results in the forearm. The GH-IGF1 axis was normal. Lifestyle modifications and adequate calcium and vitamin D intake were recommended, along with orthopedic and metabolic follow-up.

Discussion: Disproportionate short stature warrants differential diagnosis beyond endocrine causes. PSACH can mimic endocrine disorders, highlighting the key role of the endocrinologist in avoiding misdiagnosis. Early detection of complications such as osteopenia is essential to guide long-term care.

Conclusions: Timely diagnosis and a multidisciplinary approach are crucial to improving functional outcomes and quality of life in patients with PSACH.

https://doi.org/10.53853/encr.12.4.960
PDF (Español (España))
html (Español (España))

References

- Jacob P, Bhavani GSL, Shah H, Galada C, Nampoothiri S, Kamath N, et al. Pseudoachondroplasia: phenotype and genotype in 11 Indian patients. Am J Med Genet A. 2022;188(3):751-9. https://doi.org/10.1002/ajmg.a.62566

- Matsumoto H, Hori T, Mori M, Sasai H, Ohnishi H. Pseudoachondroplasia: similar radiographic findings to mucopolysaccharidosis. Pediatr Int. 2024;66(1):e15799. https://doi.org/10.1111/ped.15799

- Casas-Alba D, Fernández López A, Gean Molins E, Suero Toledano P, Martínez-Monseny A. Seudoacondroplasia: descripción de un caso de novo y otro familiar. An Pediatr. 2018;89(1):60-1. http://doi.org/10.1016/j.anpedi.2017.06.003

- Briggs MD, Wright MJ. COMP-Related Pseudoachondroplasia. En: Adam MP, Bick S, Mirzaa GM, editores. GeneReviews®, Estados Unidos: Universidad de Washington; 1993-2025. https://www.ncbi.nlm.nih.gov/books/NBK1487/

- Weiner DS, Guirguis J, Makowski M, Testa S, Shauver L, Morgan D. Orthopaedic manifestations of pseudoachondroplasia. J Child Orthop. 2019;13(4):409-16. https://doi.org/10.1302/1863-2548.13.190066

- Toral López J, González Huerta LM. Recurrent Mutation (p.Arg718Pro) in the COMP Gene with Clinical Heterogeneity of Pseudoachondroplasia. Mol Syndromol. 2023;14(4):341-6. https://doi.org/10.1159/000528980

- Jones KL, Crandall Jones M, del Campo M. Osteocondrodisplasias. En: Jones KL, Crandall Jones M, del Campo M, editores. Smith's Recognizable Patterns of Human Malformation. 8.ª ed. Philadelphia: Elsevier; 2021. p. 432-517.

- Mortier GR, Cohn DH, Cormier-Daire V, Hall C, Krakow D, Mundlos S, et al. Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A. 2019;179(12):2393-419. https://doi.org/10.1002/ajmg.a.61366

- Emery A, Albokhari D, Hoover-Fong JE. Disorders affecting cartilage matrix proteins. In: Stevenson RE, Hall JG, Goodman RM, editors. Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics. Elsevier; 2023. pp. 4340–4344.

- Albokhari D, Hoover-Fong JE. Pseudoachondroplasia and multiple epiphyseal dysplasia. In: Stevenson RE, Hall JG, Goodman RM, editors. Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics. Elsevier; 2023. pp. 4340–4344.e1

- Posey KL, Hecht JT. Novel therapeutic interventions for pseudoachondroplasia. Bone. 2017;102:60-8. https://doi.org/10.1016/j.bone.2017.03.045

- Posey KL. Curcumin and resveratrol: nutraceuticals with so much potential for pseudoachondroplasia and other ER-stress conditions. Biomolecules. 2024;14(2):154. https://doi.org/10.3390/biom14020154

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2025 Revista Colombiana de Endocrinología, Diabetes & Metabolismo

Dimensions


PlumX


Downloads

Download data is not yet available.